Pharmaceutical compositions for the treatment of capillary arteriopathy

摘要

The invention relates to the use of ergot derivatives or ergolines and particularly lisuride and terguride for preventing and treating constrictive capillary arteriopathy, a term that encompasses pulmonary arterial hypertension, endogenously or exogenously induced glomeruloscleroses, and secondary Raynaud's phenomenon or syndrome.